Sunitinib Glenmark 25 mg tvrdé kapsuly Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib glenmark 25 mg tvrdé kapsuly

glenmark pharmaceuticals s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Glenmark 12,5 mg tvrdé kapsuly Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib glenmark 12,5 mg tvrdé kapsuly

glenmark pharmaceuticals s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Pharmagen 50 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmagen 50 mg

pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Pharmagen 25 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmagen 25 mg

pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Pharmagen 12,5 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmagen 12,5 mg

pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Pharmevid 50 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmevid 50 mg

pharmevid s.r.o., slovensko - sunitinib - 44 - cytostatica

Sunitinib Pharmevid 25 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmevid 25 mg

pharmevid s.r.o., slovensko - sunitinib - 44 - cytostatica

Sunitinib Pharmevid 12,5 mg Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmevid 12,5 mg

pharmevid s.r.o., slovensko - sunitinib - 44 - cytostatica

Sutent Avrupa Birliği - Slovakça - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Znobact 500 mg filmom obalené tablety Slovakya - Slovakça - ŠÚKL (Štátny ústav pre kontrolu liečiv)

znobact 500 mg filmom obalené tablety

glenmark pharmaceuticals s.r.o., Česká republika - cefuroxím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)